81 related articles for article (PubMed ID: 23564833)
1. Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report.
Yamazaki H; Nakamura S; Nishimura T; Kodani N; Tsubokura T; Kimoto T; Sihomi H; Aibe N; Yoshida K; Koizumi M; Kagiya T
Anticancer Res; 2013 Apr; 33(4):1773-6. PubMed ID: 23564833
[TBL] [Abstract][Full Text] [Related]
2. Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy.
Yamazaki H; Nakamura S; Kobayashi K; Tsubokura T; Kodani N; Aibe N; Yoshida K; Kagiya T; Koizumi M; Yamada K
Anticancer Res; 2013 Feb; 33(2):643-6. PubMed ID: 23393361
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases.
Kwon AK; Dibiase SJ; Wang B; Hughes SL; Milcarek B; Zhu Y
Cancer; 2009 Feb; 115(4):890-8. PubMed ID: 19132728
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique.
Yamazaki H; Nakamura S; Nishimura T; Okabe H; Aibe N; Yoshida K; Kagiya T
Anticancer Res; 2013 Apr; 33(4):1685-8. PubMed ID: 23564816
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiotherapy for brain metastases--results from three different dose concepts.
Fahrig A; Ganslandt O; Lambrecht U; Grabenbauer G; Kleinert G; Sauer R; Hamm K
Strahlenther Onkol; 2007 Nov; 183(11):625-30. PubMed ID: 17960338
[TBL] [Abstract][Full Text] [Related]
6. Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.
Li GH; Liu Y; Tang JL; Zhang D; Zhou P; Yang DQ; Ma CK
Jpn J Clin Oncol; 2012 Sep; 42(9):856-60. PubMed ID: 22701036
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy using intensity-modulated radiotherapy in patients with one or two brain metastases.
Narayana A; Chang J; Yenice K; Chan K; Lymberis S; Brennan C; Gutin PH
Stereotact Funct Neurosurg; 2007; 85(2-3):82-7. PubMed ID: 17167236
[TBL] [Abstract][Full Text] [Related]
9. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
10. Radiosurgery for brain metastases from primary lung carcinoma.
Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy].
Doleželová H; Hynková L; Pospíšil P; Kazda T; Slampa P; Coupková I; Siková I; Fardus P; Svoboda T; Garčic J; Vrzal M; Selingerová I; Horová I
Klin Onkol; 2012; 25(6):445-51. PubMed ID: 23301647
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation of brain metastases with radiosurgery.
Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation for progressive brain metastases.
Bahl A; Kumar M; Sharma DN; Jothy Basu KS; Jaura MS; Rath GK; Julka PK
J Cancer Res Ther; 2009; 5(3):161-4. PubMed ID: 19841556
[TBL] [Abstract][Full Text] [Related]
14. Preliminary results of whole brain radiotherapy with concurrent trastuzumab for treatment of brain metastases in breast cancer patients.
Chargari C; Idrissi HR; Pierga JY; Bollet MA; Diéras V; Campana F; Cottu P; Fourquet A; Kirova YM
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):631-6. PubMed ID: 20932686
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
Lindvall P; Bergström P; Löfroth PO; Henriksson R; Bergenheim AT
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1460-6. PubMed ID: 15817351
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
17. [Current strategies in radiation therapy for brain metastases].
Nakasu Y
No Shinkei Geka; 2007 Jan; 35(1):7-16. PubMed ID: 17228763
[No Abstract] [Full Text] [Related]
18. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
Radiother Oncol; 2006 Oct; 81(1):18-24. PubMed ID: 16978720
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
[TBL] [Abstract][Full Text] [Related]
20. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
